1,2-dihydroxy-4-(nitroethenyl)benzene (SL-1)

01/01/2018 - "In the present study, we explored the anti-colorectal cancer (CRC) activity of SL-1, a DNA-directed N-mustard-quinoline conjugate. "

04/01/2002 - "Fifty patients were included in the study and were treated with a Storz Minilith Sl-1 shock wave generator. "

03/09/2012 - "tuberculosis, suggesting an avenue for perturbing SL-1 biosynthesis in vivo. "
07/03/2007 - "tuberculosis confirmed their essential role in SL-1 biosynthesis and their order of action. "
08/01/2004 - "tuberculosis resulted in the loss of T2S and SL-1 formation, respectively. "
05/13/2003 - "tuberculosis, is required for SL-1 production. "
06/01/2011 - "tuberculosis, its cell wall may undergo changes in SL-1 and SL(1278) contents during a natural course of infection and this may serve as an important adaptive strategy for M. "

01/01/2020 - "An Mtb mutant lacking SL-1, MtbΔpks2, shows attenuated lysosomal rewiring compared with the WT Mtb in both in vitro and in vivo infections. "
12/01/2011 - "We speculated that the effect of SL-1 on M.tb pathogenicity could be associated with long-term survival and persistence establishment during infection. "
09/01/2007 - "Microscopic observation revealed that infection of SL-1 cells with AfMNPV resulted in apoptosis, displaying apoptotic bodies in fluorescent-stained nuclei of AfMNPV-infected SL-1cells. "
07/03/2007 - "The loss of SL-1 (and SL(1278)) did not appear to affect bacterial replication or trafficking, suggesting that the functions of SL-1 are specific to human infection."
05/13/2003 - "Thus, we hypothesize that either MmpL8 transports molecules in addition to SL-1 that mediate host-pathogen interactions or the accumulation of SL(1278) in mmpL8 mutant cells interferes with other pathways required for growth during the early stages of infection."

12/29/1997 - "These observations demonstrate that inappropriate expression of SL-1 initiates a cascade of events that may represent a coordinated program leading to loss of the differentiated epithelial phenotype and gain of some characteristics of tumor cells. "
09/01/1996 - "These observations suggest that SL-1 and other MMPs may be useful targets for therapeutic intervention in cancer."
09/01/2022 - "Because of the therapeutical impacts of hydrolytic enzymes in different diseases, in particular malignancies, we aimed to produce a recombinant putative L-glutaminase (GLS ASL-1) from a recently characterized halo-thermotolerant Bacillus sp. SL-1. "